English Spanish Chinese Russian French Japanese Portuguese Hindi Telugu Tamil

Archiv der Medizin

  • ISSN: 1989-5216
  • H-Index der Zeitschrift: 22
  • Zitierbewertung der Zeitschrift: 4.96
  • Journal-Impact-Faktor: 4.44
Indiziert in
  • Genamics JournalSeek
  • Nationale Wissensinfrastruktur Chinas (CNKI)
  • Verzeichnis der Indexierung von Forschungszeitschriften (DRJI)
  • OCLC – WorldCat
  • Proquest-Vorladungen
  • Publons
  • Genfer Stiftung für medizinische Ausbildung und Forschung
  • Euro-Pub
  • Google Scholar
  • Geheime Suchmaschinenlabore
Mehr sehen
Teile diese Seite

Abstrakt

Rituximab Induced Neutropenia in a Patient with Bullous Pemphigoid

Hasan Khosravi, Maryam Abdollahi, Mehrnoosh Badakhsh, Tahereh Soori, Masoud Jafari, Gordon Bae, Maryam Daneshpazhooh

Rituximab, a chimeric monoclonal antibody against the CD20 B-cell antigen, is used to treat B-cell malignancies, rheumatoid arthritis, and autoimmune blistering diseases. Adverse events seen with rituximab include infusion reactions, infections, and late or early-onset neutropenia. Specifically, neutropenia is classified as grade III, an absolute neutrophil count (ANC) of 0.5-1.5 x 109/L, or grade IV, an ANC less than 0.5 x 109/L. In this case, we present a bullous pemphigoid (BP) patient with grade IV rituximabinduced neutropenia and safe re-treatment after two years.